Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overview of phase I trials of 2',3'-dideoxyinosine (ddI) conducted on adult patients.
Rozencweig M, McLaren C, Beltangady M, Ritter J, Canetta R, Schacter L, Kelley S, Nicaise C, Smaldone L, Dunkle L, et al. Rozencweig M, et al. Among authors: kelley s. Rev Infect Dis. 1990 Jul-Aug;12 Suppl 5:S570-5. doi: 10.1093/clinids/12.supplement_5.s570. Rev Infect Dis. 1990. PMID: 2166965 Clinical Trial.
Overview of hormonal therapy in advanced breast cancer.
Schacter LP, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L. Schacter LP, et al. Among authors: kelley s. Semin Oncol. 1990 Dec;17(6 Suppl 9):38-46. Semin Oncol. 1990. PMID: 2148026
Megestrol acetate: clinical experience.
Schacter L, Rozencweig M, Canetta R, Kelley S, Nicaise C, Smaldone L. Schacter L, et al. Among authors: kelley s. Cancer Treat Rev. 1989 Mar;16(1):49-63. doi: 10.1016/0305-7372(89)90004-2. Cancer Treat Rev. 1989. PMID: 2471590 Review.
Resistance to platinum compounds: mechanisms and beyond.
Kelley SL, Rozencweig M. Kelley SL, et al. Eur J Cancer Clin Oncol. 1989 Aug;25(8):1135-40. doi: 10.1016/0277-5379(89)90405-7. Eur J Cancer Clin Oncol. 1989. PMID: 2670584 Review. No abstract available.
Drug discovery and development in the pharmaceutical industry.
Schacter LP, Anderson C, Canetta RM, Kelley S, Nicaise C, Onetto N, Rozencweig M, Smaldone L, Winograd B. Schacter LP, et al. Among authors: kelley s. Semin Oncol. 1992 Dec;19(6):613-21. Semin Oncol. 1992. PMID: 1462163 Review.
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, Menter A, Lowe NJ, Krueger G, Brown MJ, Weiner RS, Birkhofer MJ, Warner GL, Berry KK, Linsley PS, Krueger JG, Ochs HD, Kelley SL, Kang S. Abrams JR, et al. Among authors: kelley sl. J Clin Invest. 1999 May;103(9):1243-52. doi: 10.1172/JCI5857. J Clin Invest. 1999. PMID: 10225967 Free PMC article. Clinical Trial.
Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.
Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG. Abrams JR, et al. Among authors: kelley sl. J Exp Med. 2000 Sep 4;192(5):681-94. doi: 10.1084/jem.192.5.681. J Exp Med. 2000. PMID: 10974034 Free PMC article.
Hypertension Self-Management Among African American Adults.
Sharma DP, Aycock DM, Kelley SJ, Gaillard T. Sharma DP, et al. Among authors: kelley sj. J Cardiovasc Nurs. 2025 Jan 3. doi: 10.1097/JCN.0000000000001172. Online ahead of print. J Cardiovasc Nurs. 2025. PMID: 39752575
1,310 results